EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland

Sirpa Loukovaara iD, Jari Haukka iD

Acta Ophthalmologica · 2026

DOI: 10.1111/aos.70138 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2026. Verfasst von Sirpa Loukovaara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Vitreoretinal Surgery, Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Postmenopause, Glaucoma, Estrogen Replacement Therapy, Hormone Replacement Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Hormonal replacement therapy (HRT) in postmenopausal women appears to affect glaucoma risk, but findings are inconsistent. We aimed to explore whether the use of postmenopausal HRT plays a role in glaucoma development in Finland.

Methods

The main outcome variable was glaucoma incidence measured by initiation of special reimbursement due to glaucoma. The population‐based historic cohort consisted of female participants aged ≥50 years whose incident glaucoma was recorded between January 1st, 2015, and December 31st, 2017. The main exposure of interest was postmenopausal HRT with Anatomic Therapeutic Chemical codes G03C (oestrogens), G03D (progestogens), G03F (progestogens and oestrogens in combination). The HRT treatment was initiated during 2001–2010. Frequencies and odds ratios (ORs) with 95% confidence intervals (CIs) were analyzed with logistic regression models, unadjusted and adjusted for diabetes mellitus, hospital district, socioeconomic status and statin exposure.

Results

Our nested‐case‐control study involved 1096 cases and 5480 age‐matched controls. After adjustment for confounding factors, use of any HRT was associated with an increased risk for the development of glaucoma. The risk was found in estrogen users (adjusted OR, 1.33 [95% CI, 1.17–1.52]), in progestogen users (adjusted OR, 1.25 [95% CI, 1.02–1.53]) and in combinatory estrogen–progesterone users (adjusted OR, 1.19 [95% CI, 1.01–1.39]). In the POAG subgroup, the risk remained in estrogens‐only users (adjusted OR, 1.31 [95% CI, 1.10–1.56]).

Conclusions

Our data suggests that use of any postmenopausal HRT may increase the glaucoma risk, but in POAG subgroup estrogen‐only therapy remained significant. Further research is needed to confirm the associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PostmenopauseGlaucomaEstrogen Replacement TherapyHormone Replacement TherapyIntraocular PressureHumansFemaleFinlandMiddle AgedIncidenceAgedRisk FactorsCase-Control StudiesFollow-Up StudiesRetrospective Studies

Stichwörter der Autor:innen

glaucomaglaucoma surgeryhormone replacement therapynested case–controloestrogenprogesterone

Autor:innen und Institutionen

  • Unit of Vitreoretinal Surgery, Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland.
  • Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
  • Department of Public Health, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Sirpa Loukovaara, Jari Haukka

Zitieren

APA

Loukovaara, S., & Haukka, J. (2026). Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland. Acta Ophthalmologica. https://doi.org/10.1111/aos.70138

Vancouver

Loukovaara S, Haukka J. Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland. Acta Ophthalmologica. 2026. doi:10.1111/aos.70138

BibTeX
@article{Loukovaara2026,
  author = {Loukovaara, Sirpa and Haukka, Jari},
  title = {Hormonal replacement therapy in postmenopausal women ≥50 years is associated with the incidence of glaucoma: Evidence from 6576 females in Finland},
  journal = {Acta Ophthalmologica},
  year = {2026},
  doi = {10.1111/aos.70138}
}
Kostenlos starten →